Literature DB >> 26657479

Hypoxia-Inducible Factor-1α Gene Expression and Apoptosis in Ischemia-Reperfusion Injury: A Rat Model of Early-Stage Pressure Ulcer.

Yanyan Wang1, Lihui Pu, Zhi Li, Xiuying Hu, Liping Jiang.   

Abstract

BACKGROUND: Pressure ulcer (PU) is a significant and complicated health problem. Although ischemia-reperfusion (I/R) injury has been identified as the primary mechanism in the early stage of pressure ulceration, the cellular and molecular events contributing to I/R injury of PU development are unclear.
OBJECTIVES: The aim of this study was to characterize hypoxia-inducible factor-1α (HIF-1α) expression profile and elaborate the apoptotic pathways based on an I/R injury model of PU in rats.
METHODS: Two related experiments were conducted. The purpose of Experiment 1 was to establish an animal model of early-stage PU (Stage I PU). Forty-eight rats were randomly divided into six groups of eight. Each group received three cycles of I/R, but with different magnitudes of pressure-which ranged from 100 to 270 mm Hg-except for Control Group A. On the basis of this established animal model, Experiment 2 focused on the I/R mechanism of early-stage PU. The 36 rats used in Experiment 2 were randomly divided into one control and two experimental groups; the experimental groups received the same magnitude of pressure (170 mm Hg), but either 3 or 5 I/R cycles. Tissue underneath the compressed region, including the skin and muscle tissue, was incised for immunohistochemistry, enzyme-linked immunosorbent assay, TdT-mediated dUTP nick-end labeling, and real-time polymerase chain reaction gene expression analysis.
RESULTS: HIF-1α gene expression in the compressed muscle tissue was slightly reduced in the 3 I/R group, but significantly elevated in the 5 I/R group (p < .05). The compressed tissue showed inflammation and evidence of oxidative stress reaction. ATPase activity was lower when cycles of I/R were prolonged. TdT-mediated dUTP nick-end labeling analysis showed a significant increase in the compressed muscle tissue relative to the control. Bax and Bcl-2 proteins expressed reversely. DISCUSSION: These results suggest that mitochondria-mediated apoptotic pathways may be involved in the development of early-stage PU, and HIF-1α might play a potential role for promoting apoptosis. Inflammation, oxidative stress reaction, and energy depletion may cooperate in the process of I/R injury of early-stage PU.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26657479     DOI: 10.1097/NNR.0000000000000132

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  5 in total

1.  [Effect of different time windows and interventions on skin pressure ulcers and ischemia-reperfusion injury in rats].

Authors:  Hua-Jun Wang; Shi-Xue Dai; Quan Lu; Lin-Chang Ye; Hua Li; Xi Song; Tao Hong; Wei-Hong Sha
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

2.  Neuroprotection of Intermedin Against Cerebral Ischemia/Reperfusion Injury Through Cerebral Microcirculation Improvement and Apoptosis Inhibition.

Authors:  Xin Guo; Jie Yuan; Meixi Li; Meng Wang; Peiyuan Lv
Journal:  J Mol Neurosci       Date:  2020-09-10       Impact factor: 3.444

3.  Pressure Combined with Ischemia/Reperfusion Injury Induces Deep Tissue Injury via Endoplasmic Reticulum Stress in a Rat Pressure Ulcer Model.

Authors:  Fei-Fei Cui; Ying-Ying Pan; Hao-Huang Xie; Xiao-Hui Wang; Hong-Xue Shi; Jian Xiao; Hong-Yu Zhang; Hao-Teng Chang; Li-Ping Jiang
Journal:  Int J Mol Sci       Date:  2016-02-25       Impact factor: 5.923

4.  Quantitative iTRAQ LC-MS/MS reveals muscular proteome profiles of deep pressure ulcers.

Authors:  Zan Liu; Xu Cui; Yanke Hu; Pihong Zhang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

5.  Sevoflurane Ameliorates Myocardial Cell Injury by Inducing Autophagy via the Deacetylation of LC3 by SIRT1.

Authors:  Lihua Fan; Deyuan Chen; Jianping Wang; Yini Wu; Dongli Li; Xiaoyan Yu
Journal:  Anal Cell Pathol (Amst)       Date:  2017-09-26       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.